The CartRevive™ hydrogel implant is currently being validated in a clinical trial. This ACTIVE-study, Advanced Cartilage Treatment with Injectable hydrogel Validation of the Effect, is led by dr. R.J.H. Custers, orthopedic surgeon, department of orthopedics of the University Hospital Utrecht as the Principal Investigator.
Important note:
The CartRevive™ hydrogel implant is an investigational implant designed for patients who are suffering from a relatively recent cartilage injury surrounded by healthy cartilage. It is NOT aimed at advanced stages of cartilage disease like OsteoArthritis or Rheumatoid Arthritis.
Hy2Care’s CartRevive™ hydrogel implant has not yet been approved by regulatory authorities for commercial sale and can only be used in a clinical study.